Related Experiment Video

Updated: Aug 13, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Fertility preservation in female cancer patients: current developments and future directions

S Samuel Kim1

  • 1Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California, USA. medssk@attglobal.net

Fertility and Sterility
|January 18, 2006
PubMed
Abstract

Insights

Fertility preservation options for cancer patients are advancing, with ovarian tissue cryobanking showing significant promise for future reproductive health. Ongoing research aims to improve these crucial strategies.

Area of Science:

  • Reproductive Medicine and Endocrinology
  • Oncology
  • Cryobiology

Background:

  • Cancer treatments can lead to premature ovarian failure and sterility.
  • Fertility preservation is a critical concern for cancer patients of reproductive age.
  • Ovarian tissue cryobanking is an emerging strategy for women unable to undergo other fertility preservation methods.

Purpose of the Study:

  • To review current advances in fertility preservation strategies for cancer patients.
  • To discuss future directions in fertility preservation, emphasizing ovarian tissue cryobanking.
  • To highlight the potential of ovarian tissue banking for maintaining reproductive capacity.

Main Methods:

  • Comprehensive literature search of Medline and other bibliographic databases.
  • Focus on recent publications and developments in fertility preservation.
  • Review of strategies specifically relevant to cancer patients.

Main Results:

  • Multiple fertility preservation options exist for cancer patients.
  • Many current methods are still experimental, with unproven efficacy and reliability.
  • A live birth following human ovarian tissue transplantation demonstrates clinical potential.

Conclusions:

  • The future of fertility preservation for women with cancer is promising.
  • Ovarian tissue banking is a key area with significant clinical potential.
  • Continued research is essential to improve existing strategies and address ethical considerations.

More Related Videos

Fertility Preservation in Patients with Severe Ovarian Dysfunction12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Related Concept Videos

Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...